Nutritional Support for Liver Diseases

Nutritional Support for Liver Diseases

The liver is a key organ that is responsible for the metabolism of proteins, fats, and carbohydrates and the absorption and storage of micronutrients. Unfortunately, the prevalence of chronic liver diseases at various stages of advancement in the world population is significant. Due to the physiolog...

Full description

Bibliographic Details
Main Authors:	Dominika Jamioł-Milc, Anna Gudan, Karolina Kaźmierczak-Siedlecka, Joanna Hołowko-Ziółek, Dominika Maciejewska-Markiewicz, Katarzyna Janda-Milczarek, Ewa Stachowska
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Nutrients
Subjects:	liver diseases nutrition cholangiocarcinoma NAFLD NASH cirrhosis
Online Access:	https://www.mdpi.com/2072-6643/15/16/3640

Similar Items

The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression
by: Anna Gudan, et al.
Published: (2022-12-01)

The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Ewa Stachowska, et al.
Published: (2020-11-01)

Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the Liver
by: Dominika Maciejewska, et al.
Published: (2019-11-01)

The Obscure Effect of <i>Tribulus terrestris</i> Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes Mellitus
by: Kamila Misiakiewicz-Has, et al.
Published: (2021-08-01)

Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
by: Dominika Maciejewska, et al.
Published: (2020-04-01)

Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction
by: Marcin Krawczyk, et al.
Published: (2018-11-01)

Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review
by: Elena S. George, et al.
Published: (2022-01-01)

Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
by: Pengcheng Chen, et al.
Published: (2022-12-01)

Alternative RNA Splicing in Fatty Liver Disease
by: Panyisha Wu, et al.
Published: (2021-02-01)

Nutritional Support in Coronavirus 2019 Disease
by: Ewa Stachowska, et al.
Published: (2020-06-01)

The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dominika Maciejewska-Markiewicz, et al.
Published: (2021-06-01)

Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication
by: Filippo Biagi, et al.
Published: (2023-10-01)

Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
by: Jingjing Jiao, et al.
Published: (2023-02-01)

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
by: Myriam Alexander, et al.
Published: (2019-05-01)

Estimating the cost of illness of non‐alcoholic fatty liver disease in Bangladesh
by: Shahinul Alam, et al.
Published: (2023-09-01)

Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis
by: Tanat Yongpisarn, et al.
Published: (2022-12-01)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
by: Isabel Graupera, et al.
Published: (2022-07-01)

Drug-induced fatty liver disease: An overview of pathogenesis and management
by: Sanjaya K. Satapathy, et al.
Published: (2015-11-01)

Editorial “Nutrition and Dietary Intake for Liver-Related Diseases”
by: Ewa Stachowska, et al.
Published: (2021-01-01)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dragana Savic, et al.
Published: (2020-07-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Precision Nutrition in NAFLD: Effects of a High-Fiber Intervention on the Serum Metabolome of NAFD Patients—A Pilot Study
by: Ewa Stachowska, et al.
Published: (2022-12-01)

Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
by: Salvatore Pezzino, et al.
Published: (2023-04-01)

A case of metabolic syndrome, positive antinuclear antibodies and cirrhosis.
by: Alessandro Grasso
Published: (2007-09-01)

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective
by: Jian Huang, et al.
Published: (2023-04-01)

Therapeutic Physical Exercise Programs in the Context of NASH Cirrhosis and Liver Transplantation: A Systematic Review
by: Marwin A. Farrugia, et al.
Published: (2023-02-01)

Renal resistive index in non-alcoholic fatty liver disease as an indicator of early renal affection
by: Hossam El-Din A. Mahmoud, et al.
Published: (2020-02-01)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Farzaneh Iravani, et al.
Published: (2018-10-01)

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver DiseaseSummary
by: Marc-Olivier Deguise, et al.
Published: (2021-01-01)

Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
by: Daniel Clayton-Chubb, et al.
Published: (2023-01-01)

Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients—Randomized Control Trials (RCT)
by: Dominika Maciejewska-Markiewicz, et al.
Published: (2022-10-01)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
by: Paola Dongiovanni, et al.
Published: (2021-10-01)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01)

From Liver Fat to Cancer: Perils of the Western Diet
by: Ju Youn Kim, et al.
Published: (2021-03-01)

Current and Future Treatments in the Fight against Non-Alcoholic Fatty Liver Disease
by: Benoit Smeuninx, et al.
Published: (2020-06-01)

Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
by: Norma David, et al.
Published: (2023-10-01)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
by: Ana Sandoval-Rodriguez, et al.
Published: (2022-04-01)

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01)

Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
by: Anna Gudan, et al.
Published: (2023-03-01)

Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?
by: Angeliki Papachristodoulou, et al.
Published: (2021-06-01)